UniProt ID | PDC6I_HUMAN | |
---|---|---|
UniProt AC | Q8WUM4 | |
Protein Name | Programmed cell death 6-interacting protein | |
Gene Name | PDCD6IP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 868 | |
Subcellular Localization | Cytoplasm, cytosol . Melanosome . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Secreted, exosome . Cell junction, tight junction . Midbody, Midbody ring . Identified by mass spectrometry in melanosome fractions from stage I to | |
Protein Description | Multifunctional protein involved in endocytosis, multivesicular body biogenesis, membrane repair, cytokinesis, apoptosis and maintenance of tight junction integrity. Class E VPS protein involved in concentration and sorting of cargo proteins of the multivesicular body (MVB) for incorporation into intralumenal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome. Binds to the phospholipid lysobisphosphatidic acid (LBPA) which is abundant in MVBs internal membranes. The MVB pathway requires the sequential function of ESCRT-O, -I,-II and -III complexes. [PubMed: 14739459 The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis] | |
Protein Sequence | MATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARKTERDELLKDLQQSIAREPSAPSIPTPAYQSSPAGGHAPTPPTPAPRTMPPTKPQPPARPPPPVLPANRAPSATAPSPVGAGTAAPAPSQTPGSAPPPQAQGPPYPTYPGYPGYCQMPMPMGYNPYAYGQYNMPYPPVYHQSPGQAPYPGPQQPSYPFPQPPQQSYYPQQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATFISVQL ------CCEEEEEEE | 15.95 | 22223895 | |
3 | Phosphorylation | -----MATFISVQLK -----CCEEEEEEEC | 21.87 | 23401153 | |
6 | Phosphorylation | --MATFISVQLKKTS --CCEEEEEEECCCC | 10.30 | 23401153 | |
10 | Methylation | TFISVQLKKTSEVDL EEEEEEECCCCCCCH | 36.59 | - | |
11 | Malonylation | FISVQLKKTSEVDLA EEEEEECCCCCCCHH | 66.91 | 26320211 | |
11 (in isoform 2) | Malonylation | - | 66.91 | 26320211 | |
12 | Phosphorylation | ISVQLKKTSEVDLAK EEEEECCCCCCCHHH | 28.65 | 20873877 | |
13 | Phosphorylation | SVQLKKTSEVDLAKP EEEECCCCCCCHHHH | 44.49 | 25849741 | |
13 (in isoform 2) | Phosphorylation | - | 44.49 | 27251275 | |
19 | Ubiquitination | TSEVDLAKPLVKFIQ CCCCCHHHHHHHHHH | 46.30 | 21890473 | |
19 | Ubiquitination | TSEVDLAKPLVKFIQ CCCCCHHHHHHHHHH | 46.30 | 21890473 | |
19 | Acetylation | TSEVDLAKPLVKFIQ CCCCCHHHHHHHHHH | 46.30 | 23236377 | |
19 | Malonylation | TSEVDLAKPLVKFIQ CCCCCHHHHHHHHHH | 46.30 | 26320211 | |
19 | Ubiquitination | TSEVDLAKPLVKFIQ CCCCCHHHHHHHHHH | 46.30 | 23000965 | |
19 (in isoform 2) | Malonylation | - | 46.30 | 26320211 | |
23 | Ubiquitination | DLAKPLVKFIQQTYP CHHHHHHHHHHHHCC | 44.42 | 21890473 | |
23 | Ubiquitination | DLAKPLVKFIQQTYP CHHHHHHHHHHHHCC | 44.42 | 21890473 | |
23 | Acetylation | DLAKPLVKFIQQTYP CHHHHHHHHHHHHCC | 44.42 | 25953088 | |
23 | Ubiquitination | DLAKPLVKFIQQTYP CHHHHHHHHHHHHCC | 44.42 | 23000965 | |
25 | Ubiquitination | AKPLVKFIQQTYPSG HHHHHHHHHHHCCCC | 2.16 | 22817900 | |
39 | Phosphorylation | GGEEQAQYCRAAEEL CHHHHHHHHHHHHHH | 6.21 | 22817900 | |
40 | Glutathionylation | GEEQAQYCRAAEELS HHHHHHHHHHHHHHH | 1.26 | 22555962 | |
40 | S-nitrosylation | GEEQAQYCRAAEELS HHHHHHHHHHHHHHH | 1.26 | 2212679 | |
48 | Acetylation | RAAEELSKLRRAAVG HHHHHHHHHHHHHHC | 59.65 | 19608861 | |
48 | Malonylation | RAAEELSKLRRAAVG HHHHHHHHHHHHHHC | 59.65 | 26320211 | |
48 | Ubiquitination | RAAEELSKLRRAAVG HHHHHHHHHHHHHHC | 59.65 | 33845483 | |
48 (in isoform 2) | Malonylation | - | 59.65 | 26320211 | |
60 | Acetylation | AVGRPLDKHEGALET HHCCCCCCCCCHHHH | 51.76 | 23749302 | |
60 | Ubiquitination | AVGRPLDKHEGALET HHCCCCCCCCCHHHH | 51.76 | - | |
95 | Ubiquitination | QICLTFTWKDAFDKG EEEEEEEEHHCCCCC | 7.73 | 24816145 | |
100 | Ubiquitination | FTWKDAFDKGSLFGG EEEHHCCCCCCCCCH | 57.01 | 24816145 | |
101 | Ubiquitination | TWKDAFDKGSLFGGS EEHHCCCCCCCCCHH | 43.90 | 21890473 | |
101 | Ubiquitination | TWKDAFDKGSLFGGS EEHHCCCCCCCCCHH | 43.90 | 21890473 | |
101 | Acetylation | TWKDAFDKGSLFGGS EEHHCCCCCCCCCHH | 43.90 | 23236377 | |
101 | Ubiquitination | TWKDAFDKGSLFGGS EEHHCCCCCCCCCHH | 43.90 | 27667366 | |
103 | O-linked_Glycosylation | KDAFDKGSLFGGSVK HHCCCCCCCCCHHHH | 26.68 | 23301498 | |
103 | Phosphorylation | KDAFDKGSLFGGSVK HHCCCCCCCCCHHHH | 26.68 | 62168483 | |
108 | Phosphorylation | KGSLFGGSVKLALAS CCCCCCHHHHHHHHH | 19.23 | 23684312 | |
108 (in isoform 2) | Phosphorylation | - | 19.23 | 24719451 | |
113 | Ubiquitination | GGSVKLALASLGYEK CHHHHHHHHHCCCCC | 4.88 | 24816145 | |
115 | Phosphorylation | SVKLALASLGYEKSC HHHHHHHHCCCCCHH | 24.15 | 28152594 | |
118 | Phosphorylation | LALASLGYEKSCVLF HHHHHCCCCCHHHHH | 26.02 | 28152594 | |
118 | Ubiquitination | LALASLGYEKSCVLF HHHHHCCCCCHHHHH | 26.02 | 24816145 | |
122 | Ubiquitination | SLGYEKSCVLFNCAA HCCCCCHHHHHHHHH | 4.58 | 24816145 | |
123 | Ubiquitination | LGYEKSCVLFNCAAL CCCCCHHHHHHHHHH | 9.86 | 24816145 | |
127 | Ubiquitination | KSCVLFNCAALASQI CHHHHHHHHHHHHHH | 1.51 | 24816145 | |
128 | Ubiquitination | SCVLFNCAALASQIA HHHHHHHHHHHHHHH | 13.45 | 24816145 | |
157 | Phosphorylation | AKHYQFASGAFLHIK HHHHHHCCCCCHHHH | 31.76 | 28348404 | |
160 | Ubiquitination | YQFASGAFLHIKETV HHHCCCCCHHHHHHH | 6.10 | 21890473 | |
165 | Ubiquitination | GAFLHIKETVLSALS CCCHHHHHHHHHHHH | 43.47 | 21890473 | |
166 | Phosphorylation | AFLHIKETVLSALSR CCHHHHHHHHHHHHC | 23.03 | 19413330 | |
167 | Ubiquitination | FLHIKETVLSALSRE CHHHHHHHHHHHHCC | 4.11 | 23503661 | |
169 | Phosphorylation | HIKETVLSALSREPT HHHHHHHHHHHCCCC | 23.87 | 21712546 | |
172 | Ubiquitination | ETVLSALSREPTVDI HHHHHHHHCCCCCCC | 34.02 | 23503661 | |
184 | Ubiquitination | VDISPDTVGTLSLIM CCCCCCCHHHHHHHH | 7.80 | 24816145 | |
186 | Phosphorylation | ISPDTVGTLSLIMLA CCCCCHHHHHHHHHH | 14.61 | 46162323 | |
189 | Ubiquitination | DTVGTLSLIMLAQAQ CCHHHHHHHHHHHHH | 2.76 | 24816145 | |
209 | Malonylation | KATRDKMKDAIIAKL HHCHHHHHHHHHHHH | 50.15 | 26320211 | |
209 | Ubiquitination | KATRDKMKDAIIAKL HHCHHHHHHHHHHHH | 50.15 | 33845483 | |
209 (in isoform 2) | Malonylation | - | 50.15 | 26320211 | |
215 | Ubiquitination | MKDAIIAKLANQAAD HHHHHHHHHHHHHHH | 37.41 | 21890473 | |
215 | Acetylation | MKDAIIAKLANQAAD HHHHHHHHHHHHHHH | 37.41 | 19608861 | |
215 | Ubiquitination | MKDAIIAKLANQAAD HHHHHHHHHHHHHHH | 37.41 | 22817900 | |
223 | Phosphorylation | LANQAADYFGDAFKQ HHHHHHHHHHHHHHH | 12.53 | 28152594 | |
229 | Acetylation | DYFGDAFKQCQYKDT HHHHHHHHHCCCCCC | 52.46 | 25953088 | |
229 | Ubiquitination | DYFGDAFKQCQYKDT HHHHHHHHHCCCCCC | 52.46 | 32015554 | |
234 | Ubiquitination | AFKQCQYKDTLPKEV HHHHCCCCCCCCHHH | 20.54 | - | |
239 | Ubiquitination | QYKDTLPKEVFPVLA CCCCCCCHHHHHHHH | 70.40 | 29967540 | |
258 | Phosphorylation | IMQANAEYHQSILAK HHHCCHHHHHHHHHH | 11.62 | 46162341 | |
269 | Acetylation | ILAKQQKKFGEEIAR HHHHHHHHHHHHHHH | 55.02 | 25953088 | |
269 | Ubiquitination | ILAKQQKKFGEEIAR HHHHHHHHHHHHHHH | 55.02 | 29967540 | |
274 | Ubiquitination | QKKFGEEIARLQHAA HHHHHHHHHHHHHHH | 2.05 | 29967540 | |
285 | Acetylation | QHAAELIKTVASRYD HHHHHHHHHHHHHCH | 49.96 | 25953088 | |
285 | Malonylation | QHAAELIKTVASRYD HHHHHHHHHHHHHCH | 49.96 | 26320211 | |
285 | Ubiquitination | QHAAELIKTVASRYD HHHHHHHHHHHHHCH | 49.96 | 32015554 | |
290 | Ubiquitination | LIKTVASRYDEYVNV HHHHHHHHCHHCCCH | 32.93 | 32015554 | |
290 (in isoform 2) | Malonylation | - | 32.93 | 26320211 | |
294 | Phosphorylation | VASRYDEYVNVKDFS HHHHCHHCCCHHHHH | 8.40 | 27251275 | |
296 | Ubiquitination | SRYDEYVNVKDFSDK HHCHHCCCHHHHHHH | 33.93 | 23000965 | |
298 | Acetylation | YDEYVNVKDFSDKIN CHHCCCHHHHHHHHH | 48.10 | 23236377 | |
298 | Ubiquitination | YDEYVNVKDFSDKIN CHHCCCHHHHHHHHH | 48.10 | 32015554 | |
299 (in isoform 2) | Phosphorylation | - | 43.96 | 27642862 | |
301 | Ubiquitination | YVNVKDFSDKINRAL CCCHHHHHHHHHHHH | 48.40 | 23000965 | |
303 | Acetylation | NVKDFSDKINRALAA CHHHHHHHHHHHHHH | 40.45 | 26822725 | |
303 | Malonylation | NVKDFSDKINRALAA CHHHHHHHHHHHHHH | 40.45 | 26320211 | |
303 | Ubiquitination | NVKDFSDKINRALAA CHHHHHHHHHHHHHH | 40.45 | 32015554 | |
308 | Ubiquitination | SDKINRALAAAKKDN HHHHHHHHHHHHHCC | 2.77 | 24816145 | |
308 (in isoform 2) | Malonylation | - | 2.77 | 26320211 | |
311 | Ubiquitination | INRALAAAKKDNDFI HHHHHHHHHHCCCCC | 17.52 | 21890473 | |
312 | Ubiquitination | NRALAAAKKDNDFIY HHHHHHHHHCCCCCC | 56.80 | 24816145 | |
313 | Malonylation | RALAAAKKDNDFIYH HHHHHHHHCCCCCCC | 57.97 | 26320211 | |
313 | Ubiquitination | RALAAAKKDNDFIYH HHHHHHHHCCCCCCC | 57.97 | 24816145 | |
316 | Ubiquitination | AAAKKDNDFIYHDRV HHHHHCCCCCCCCCC | 41.26 | 21890473 | |
317 | Ubiquitination | AAKKDNDFIYHDRVP HHHHCCCCCCCCCCC | 8.18 | 24816145 | |
318 | Ubiquitination | AKKDNDFIYHDRVPD HHHCCCCCCCCCCCC | 3.13 | 33845483 | |
318 (in isoform 2) | Malonylation | - | 3.13 | 26320211 | |
319 | Phosphorylation | KKDNDFIYHDRVPDL HHCCCCCCCCCCCCH | 9.54 | 27259358 | |
322 | Methylation | NDFIYHDRVPDLKDL CCCCCCCCCCCHHHC | 28.67 | - | |
324 (in isoform 2) | Phosphorylation | - | 41.95 | 27642862 | |
327 | Acetylation | HDRVPDLKDLDPIGK CCCCCCHHHCCCCCC | 64.72 | 25953088 | |
327 | Ubiquitination | HDRVPDLKDLDPIGK CCCCCCHHHCCCCCC | 64.72 | 32015554 | |
332 | Ubiquitination | DLKDLDPIGKATLVK CHHHCCCCCCEEEEE | 9.86 | 32015554 | |
334 | Acetylation | KDLDPIGKATLVKST HHCCCCCCEEEEECC | 38.63 | 25953088 | |
334 | Ubiquitination | KDLDPIGKATLVKST HHCCCCCCEEEEECC | 38.63 | 29967540 | |
339 | Acetylation | IGKATLVKSTPVNVP CCCEEEEECCCCCCC | 52.29 | 23236377 | |
339 | Malonylation | IGKATLVKSTPVNVP CCCEEEEECCCCCCC | 52.29 | 26320211 | |
339 | Ubiquitination | IGKATLVKSTPVNVP CCCEEEEECCCCCCC | 52.29 | 32015554 | |
340 | Phosphorylation | GKATLVKSTPVNVPI CCEEEEECCCCCCCC | 30.39 | 25627689 | |
341 | Phosphorylation | KATLVKSTPVNVPIS CEEEEECCCCCCCCH | 26.07 | 25627689 | |
344 | Ubiquitination | LVKSTPVNVPISQKF EEECCCCCCCCHHHH | 34.74 | 32015554 | |
344 (in isoform 2) | Malonylation | - | 34.74 | 26320211 | |
350 | Acetylation | VNVPISQKFTDLFEK CCCCCHHHHHHHHHH | 43.36 | 23236377 | |
350 | Ubiquitination | VNVPISQKFTDLFEK CCCCCHHHHHHHHHH | 43.36 | 23000965 | |
355 | Ubiquitination | SQKFTDLFEKMVPVS HHHHHHHHHHHCCCC | 10.63 | 21890473 | |
355 | Ubiquitination | SQKFTDLFEKMVPVS HHHHHHHHHHHCCCC | 10.63 | 23000965 | |
357 | Ubiquitination | KFTDLFEKMVPVSVQ HHHHHHHHHCCCCHH | 37.55 | 21906983 | |
362 | Ubiquitination | FEKMVPVSVQQSLAA HHHHCCCCHHHHHHH | 14.24 | 23503661 | |
366 | Phosphorylation | VPVSVQQSLAAYNQR CCCCHHHHHHHHHHH | 11.68 | 50564661 | |
370 | Phosphorylation | VQQSLAAYNQRKADL HHHHHHHHHHHHHHH | 13.25 | 50564669 | |
374 | Ubiquitination | LAAYNQRKADLVNRS HHHHHHHHHHHHHHH | 36.17 | 24816145 | |
379 | Ubiquitination | QRKADLVNRSIAQMR HHHHHHHHHHHHHHH | 39.00 | 24816145 | |
416 | Phosphorylation | SGDTVPQSILTKSRS CCCCCCHHHHHHCCH | 17.31 | 24719451 | |
421 | Phosphorylation | PQSILTKSRSVIEQG CHHHHHHCCHHHHHC | 25.26 | 29514088 | |
423 | Phosphorylation | SILTKSRSVIEQGGI HHHHHCCHHHHHCCH | 34.24 | 29514088 | |
438 | Ubiquitination | QTVDQLIKELPELLQ HHHHHHHHHHHHHHH | 62.89 | 29967540 | |
443 | Ubiquitination | LIKELPELLQRNREI HHHHHHHHHHHHHHH | 4.69 | 29967540 | |
448 | Ubiquitination | PELLQRNREILDESL HHHHHHHHHHHHHHH | 34.22 | 21963094 | |
450 | Ubiquitination | LLQRNREILDESLRL HHHHHHHHHHHHHHH | 5.47 | 27667366 | |
453 | Ubiquitination | RNREILDESLRLLDE HHHHHHHHHHHHCCH | 48.50 | 21963094 | |
455 | Ubiquitination | REILDESLRLLDEEE HHHHHHHHHHCCHHH | 4.15 | 27667366 | |
456 | Methylation | EILDESLRLLDEEEA HHHHHHHHHCCHHHC | 42.35 | - | |
464 | Phosphorylation | LLDEEEATDNDLRAK HCCHHHCCCHHHHHH | 38.32 | 110755291 | |
464 | Ubiquitination | LLDEEEATDNDLRAK HCCHHHCCCHHHHHH | 38.32 | 25015289 | |
469 | Ubiquitination | EATDNDLRAKFKERW HCCCHHHHHHHHHHH | 38.30 | 25015289 | |
471 | Ubiquitination | TDNDLRAKFKERWQR CCHHHHHHHHHHHHC | 51.00 | 29967540 | |
476 | Ubiquitination | RAKFKERWQRTPSNE HHHHHHHHHCCCCCC | 7.97 | 29967540 | |
479 | Phosphorylation | FKERWQRTPSNELYK HHHHHHCCCCCCCCH | 18.90 | 25159151 | |
481 | Phosphorylation | ERWQRTPSNELYKPL HHHHCCCCCCCCHHH | 42.18 | 25159151 | |
481 | Ubiquitination | ERWQRTPSNELYKPL HHHHCCCCCCCCHHH | 42.18 | 23503661 | |
484 (in isoform 2) | Phosphorylation | - | 8.56 | 24719451 | |
485 | Phosphorylation | RTPSNELYKPLRAEG CCCCCCCCHHHHCCC | 12.37 | 28258704 | |
485 | Ubiquitination | RTPSNELYKPLRAEG CCCCCCCCHHHHCCC | 12.37 | 23503661 | |
486 | Acetylation | TPSNELYKPLRAEGT CCCCCCCHHHHCCCC | 50.64 | 23954790 | |
486 | Malonylation | TPSNELYKPLRAEGT CCCCCCCHHHHCCCC | 50.64 | 26320211 | |
486 | Succinylation | TPSNELYKPLRAEGT CCCCCCCHHHHCCCC | 50.64 | 23954790 | |
486 | Ubiquitination | TPSNELYKPLRAEGT CCCCCCCHHHHCCCC | 50.64 | 23000965 | |
490 | Ubiquitination | ELYKPLRAEGTNFRT CCCHHHHCCCCCHHH | 27.53 | 23503661 | |
490 (in isoform 2) | Phosphorylation | - | 27.53 | 27642862 | |
491 | Ubiquitination | LYKPLRAEGTNFRTV CCHHHHCCCCCHHHH | 61.18 | 23000965 | |
491 (in isoform 2) | Malonylation | - | 61.18 | 26320211 | |
500 | Ubiquitination | TNFRTVLDKAVQADG CCHHHHHHHHHHCCC | 32.31 | 24816145 | |
501 | Acetylation | NFRTVLDKAVQADGQ CHHHHHHHHHHCCCC | 46.42 | 25953088 | |
501 | Ubiquitination | NFRTVLDKAVQADGQ CHHHHHHHHHHCCCC | 46.42 | 23000965 | |
505 | Ubiquitination | VLDKAVQADGQVKEC HHHHHHHCCCCHHHH | 19.12 | 24816145 | |
506 | Ubiquitination | LDKAVQADGQVKECY HHHHHHCCCCHHHHH | 30.85 | 21890473 | |
506 | Ubiquitination | LDKAVQADGQVKECY HHHHHHCCCCHHHHH | 30.85 | 23000965 | |
510 | Ubiquitination | VQADGQVKECYQSHR HHCCCCHHHHHHHCC | 33.89 | 29967540 | |
512 | Glutathionylation | ADGQVKECYQSHRDT CCCCHHHHHHHCCCE | 2.87 | 22555962 | |
515 | Ubiquitination | QVKECYQSHRDTIVL CHHHHHHHCCCEEEE | 8.26 | 29967540 | |
517 | Ubiquitination | KECYQSHRDTIVLLC HHHHHHCCCEEEEEE | 48.27 | 23000965 | |
522 | Ubiquitination | SHRDTIVLLCKPEPE HCCCEEEEEECCCHH | 4.03 | 23000965 | |
524 | Glutathionylation | RDTIVLLCKPEPELN CCEEEEEECCCHHHC | 6.38 | 22555962 | |
525 | Acetylation | DTIVLLCKPEPELNA CEEEEEECCCHHHCC | 53.00 | 26051181 | |
541 | Ubiquitination | IPSANPAKTMQGSEV CCCCCCCCCCCHHHH | 45.87 | 32015554 | |
543 | Sulfoxidation | SANPAKTMQGSEVVN CCCCCCCCCHHHHHH | 4.13 | 21406390 | |
546 | Ubiquitination | PAKTMQGSEVVNVLK CCCCCCHHHHHHHHH | 15.44 | 32015554 | |
554 | Phosphorylation | EVVNVLKSLLSNLDE HHHHHHHHHHHCHHH | 30.31 | 28348404 | |
557 | Phosphorylation | NVLKSLLSNLDEVKK HHHHHHHHCHHHHHH | 40.41 | 20860994 | |
561 | Ubiquitination | SLLSNLDEVKKEREG HHHHCHHHHHHHHHH | 60.44 | 21890473 | |
563 | Ubiquitination | LSNLDEVKKEREGLE HHCHHHHHHHHHHHH | 47.04 | 29967540 | |
564 | Ubiquitination | SNLDEVKKEREGLEN HCHHHHHHHHHHHHH | 68.15 | - | |
566 | Ubiquitination | LDEVKKEREGLENDL HHHHHHHHHHHHHHH | 52.76 | 21890473 | |
568 | Ubiquitination | EVKKEREGLENDLKS HHHHHHHHHHHHHHH | 44.50 | 29967540 | |
575 | Phosphorylation | GLENDLKSVNFDMTS HHHHHHHHCCHHHHH | 29.59 | 25159151 | |
580 | Sulfoxidation | LKSVNFDMTSKFLTA HHHCCHHHHHHHHHH | 3.89 | 30846556 | |
581 | Phosphorylation | KSVNFDMTSKFLTAL HHCCHHHHHHHHHHH | 30.52 | 27470641 | |
606 | Methylation | LSVTELDRVYGGLTT CCHHHHHHHHCCHHH | 35.86 | - | |
608 | Phosphorylation | VTELDRVYGGLTTKV HHHHHHHHCCHHHHH | 13.33 | 28152594 | |
612 | Phosphorylation | DRVYGGLTTKVQESL HHHHCCHHHHHHHHH | 28.04 | 24719451 | |
613 | Phosphorylation | RVYGGLTTKVQESLK HHHCCHHHHHHHHHH | 33.97 | 24719451 | |
613 (in isoform 2) | Phosphorylation | - | 33.97 | 24719451 | |
614 | Ubiquitination | VYGGLTTKVQESLKK HHCCHHHHHHHHHHH | 36.36 | 29967540 | |
617 (in isoform 2) | Phosphorylation | - | 62.11 | 24719451 | |
618 (in isoform 2) | Phosphorylation | - | 28.53 | 24719451 | |
619 | Ubiquitination | TTKVQESLKKQEGLL HHHHHHHHHHCCCHH | 8.70 | 29967540 | |
620 | Acetylation | TKVQESLKKQEGLLK HHHHHHHHHCCCHHH | 62.78 | 25953088 | |
627 | Ubiquitination | KKQEGLLKNIQVSHQ HHCCCHHHHHHHCHH | 57.98 | 29967540 | |
632 | Ubiquitination | LLKNIQVSHQEFSKM HHHHHHHCHHHHHHH | 11.77 | 29967540 | |
638 | Neddylation | VSHQEFSKMKQSNNE HCHHHHHHHHHCCCH | 56.27 | 32015554 | |
638 | Ubiquitination | VSHQEFSKMKQSNNE HCHHHHHHHHHCCCH | 56.27 | 21906983 | |
640 | Ubiquitination | HQEFSKMKQSNNEAN HHHHHHHHHCCCHHH | 55.07 | 21906983 | |
643 | Neddylation | FSKMKQSNNEANLRE HHHHHHCCCHHHHHH | 48.11 | 32015554 | |
643 | Ubiquitination | FSKMKQSNNEANLRE HHHHHHCCCHHHHHH | 48.11 | 27667366 | |
645 | Ubiquitination | KMKQSNNEANLREEV HHHHCCCHHHHHHHH | 43.09 | 27667366 | |
654 | Ubiquitination | NLREEVLKNLATAYD HHHHHHHHHHHHHHH | 55.90 | 25015289 | |
659 | Ubiquitination | VLKNLATAYDNFVEL HHHHHHHHHHHHHHH | 12.22 | 25015289 | |
671 | Ubiquitination | VELVANLKEGTKFYN HHHHHHHHCCCCHHH | 54.64 | 23503661 | |
675 | Ubiquitination | ANLKEGTKFYNELTE HHHHCCCCHHHHHHH | 57.62 | 23503661 | |
676 | Ubiquitination | NLKEGTKFYNELTEI HHHCCCCHHHHHHHH | 8.76 | 23503661 | |
680 | Ubiquitination | GTKFYNELTEILVRF CCCHHHHHHHHHHHH | 4.66 | 23503661 | |
690 | Ubiquitination | ILVRFQNKCSDIVFA HHHHHHHHCCCCEEE | 25.08 | 24816145 | |
692 | Phosphorylation | VRFQNKCSDIVFARK HHHHHHCCCCEEECC | 31.79 | 166220823 | |
695 | Ubiquitination | QNKCSDIVFARKTER HHHCCCCEEECCHHH | 3.54 | 24816145 | |
695 (in isoform 2) | Malonylation | - | 3.54 | 32601280 | |
707 | Acetylation | TERDELLKDLQQSIA HHHHHHHHHHHHHHH | 69.85 | 25953088 | |
707 | Ubiquitination | TERDELLKDLQQSIA HHHHHHHHHHHHHHH | 69.85 | 23000965 | |
712 | Ubiquitination | LLKDLQQSIAREPSA HHHHHHHHHHHCCCC | 12.78 | 21890473 | |
712 | Phosphorylation | LLKDLQQSIAREPSA HHHHHHHHHHHCCCC | 12.78 | 29255136 | |
712 | Ubiquitination | LLKDLQQSIAREPSA HHHHHHHHHHHCCCC | 12.78 | 23000965 | |
718 | Phosphorylation | QSIAREPSAPSIPTP HHHHHCCCCCCCCCC | 48.32 | 23898821 | |
721 | Phosphorylation | AREPSAPSIPTPAYQ HHCCCCCCCCCCCCC | 40.70 | 69009511 | |
723 (in isoform 2) | Phosphorylation | - | 36.35 | 27251275 | |
724 | Phosphorylation | PSAPSIPTPAYQSSP CCCCCCCCCCCCCCC | 20.91 | 30278072 | |
726 (in isoform 2) | Phosphorylation | - | 19.92 | 27251275 | |
727 | Phosphorylation | PSIPTPAYQSSPAGG CCCCCCCCCCCCCCC | 15.33 | 30278072 | |
729 | Phosphorylation | IPTPAYQSSPAGGHA CCCCCCCCCCCCCCC | 26.13 | 23401153 | |
730 | Phosphorylation | PTPAYQSSPAGGHAP CCCCCCCCCCCCCCC | 11.84 | 30278072 | |
732 (in isoform 2) | Phosphorylation | - | 38.25 | 27642862 | |
734 (in isoform 2) | Phosphorylation | - | 18.85 | 27251275 | |
735 | Phosphorylation | QSSPAGGHAPTPPTP CCCCCCCCCCCCCCC | 27.84 | 32142685 | |
738 | O-linked_Glycosylation | PAGGHAPTPPTPAPR CCCCCCCCCCCCCCC | 42.56 | OGP | |
738 | Phosphorylation | PAGGHAPTPPTPAPR CCCCCCCCCCCCCCC | 42.56 | 30278072 | |
741 | Phosphorylation | GHAPTPPTPAPRTMP CCCCCCCCCCCCCCC | 33.03 | 25159151 | |
745 | Methylation | TPPTPAPRTMPPTKP CCCCCCCCCCCCCCC | 45.84 | 24129315 | |
746 | Phosphorylation | PPTPAPRTMPPTKPQ CCCCCCCCCCCCCCC | 32.73 | 18669648 | |
751 | Acetylation | PRTMPPTKPQPPARP CCCCCCCCCCCCCCC | 47.64 | 23954790 | |
751 | Methylation | PRTMPPTKPQPPARP CCCCCCCCCCCCCCC | 47.64 | - | |
751 | Ubiquitination | PRTMPPTKPQPPARP CCCCCCCCCCCCCCC | 47.64 | 23000965 | |
756 | Ubiquitination | PTKPQPPARPPPPVL CCCCCCCCCCCCCCC | 43.21 | 21890473 | |
756 | Ubiquitination | PTKPQPPARPPPPVL CCCCCCCCCCCCCCC | 43.21 | 21890473 | |
757 | Methylation | TKPQPPARPPPPVLP CCCCCCCCCCCCCCC | 50.46 | - | |
767 | Methylation | PPVLPANRAPSATAP CCCCCCCCCCCCCCC | 50.40 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PDC6I_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PDC6I_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-48 AND LYS-215, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-730; THR-738 ANDTHR-741, AND MASS SPECTROMETRY. |